HAEMONETICS CORP - Common Stock (HAE)

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / Common Stock
Shares outstanding
47,898,935
Total 13F shares
51,250,356
Share change
+112,206
Total reported value
$1,791,862,985
Price per share
$34.98
Number of holders
160
Value change
+$9,515,385
Number of buys
97
Number of sells
55

Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q1 2016

As of 31 Mar 2016 HAEMONETICS CORP - Common Stock (HAE) had 160 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 51,250,356 shares of stock of the company.
Largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Fund Advisors, Black Creek Investment Management Inc., Neuberger Berman Group LLC, WESTWOOD HOLDINGS GROUP INC, WELLS FARGO & COMPANY/MN, WELLINGTON MANAGEMENT GROUP LLP, FULLER & THALER ASSET MANAGEMENT, INC., and DIMENSIONAL FUND ADVISORS LP.
This table shows 160 institutional shareholders of the security as of 31 Mar 2016.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.